Pasithea Therapeutics Cor...
2.42
-0.07 (-2.81%)
At close: Jan 15, 2025, 3:28 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a 486.56K 15.06K n/a
Cost of Revenue 648.45K 113.19K 17.27K n/a
Gross Profit -648.45K 373.36K -2.21K n/a
Operating Income -15.98M -14.82M -4.51M -40.98K
Interest Income n/a 102.00 508.00 n/a
Pretax Income -15.51M -13.94M -2.17M -40.98K
Net Income -15.96M -13.06M -2.17M -40.98K
Selling & General & Admin 7.88M 12.52M 4.51M 40.98K
Research & Development 8.10M 2.67M n/a n/a
Other Expenses n/a 44.72K n/a n/a
Operating Expenses 15.98M 15.19M 4.51M 40.98K
Interest Expense n/a 102.00 508.00 n/a
Selling & Marketing Expenses -7.87B 2.60M n/a n/a
Cost & Expenses 15.98M 15.30M 4.52M 40.98K
Income Tax n/a -879.97K 508.00 -61.48K
Shares Outstanding (Basic) 1.26M 1.26M 1.15M 688.92K
Shares Outstanding (Diluted) 1.23M 1.26M 1.15M 688.92K
EPS (Basic) -12.65 -10.34 -1.89 -0.06
EPS (Diluted) -13.01 -10.34 -1.89 -0.06
EBITDA -15.33M -12.58M -4.51M n/a
Depreciation & Amortization 648.45K 5.09K 1.38K 61.48K